查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1904573

伴侶動物基因體學和DNA檢測市場預測至2032年：按檢測類型、動物類型、通路、技術、應用、最終用戶和地區分類的全球分析

Companion Animal Genomics & DNA Testing Market Forecasts to 2032 - Global Analysis By Test Type, Animal Type, Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球伴侶動物基因組學和 DNA 檢測市場預計在 2025 年達到 8.6455 億美元，預計到 2032 年將達到 15.1075 億美元，在預測期內的複合年成長率為 8.3%。

伴侶動物基因組學和DNA檢測是指對寵物（例如犬貓）的遺傳物質進行科學分析，以了解其品種組成、遺傳特徵、健康風險和祖先資訊。該領域以數十年來經典的遺傳學和現代分子生物學為基礎，應用先進的DNA定序和生物資訊技術，為預防保健、個人化營養、負責任的繁殖和疾病管理提供支援。這一領域使獸醫、繁殖者和寵物飼主能夠預測遺傳疾病、最佳化健康護理方案並提高寵物的生活品質。技術的進步正在塑造精準獸醫學的未來，同時也在維繫人類與伴侶動物之間的古老紐帶。

寵物擁有率不斷提高以及寵物的人性化

寵物飼養量的不斷成長以及人類與寵物之間建立的深厚情感紐帶是推動成長要素。寵物越來越被視為家庭成員，飼主投資先進的醫療保健、健康監測和預防性診斷。基因檢測有助於飼主及早了解寵物的品種特徵、行為傾向和遺傳健康風險，從而實現主動護理。這種對動物由來已久的愛，在現代科學的推動下，持續推動對基於基因組的寵物解決方案的旺盛需求。

基因檢測高成本

伴侶動物基因檢測的高昂費用是限制市場發展的重要因素，尤其是在價格敏感地區。先進的DNA定序、生物資訊分析和實驗室基礎設施顯著增加了檢測成本。儘管人們對基因檢測的認知不斷提高，但這些高昂的費用仍然限制了許多寵物飼主，尤其是在新興經濟體的寵物主人，接受基因檢測的意願。此外，高昂的價格也阻礙了常規或重複檢測，從而減緩了市場滲透率。在檢測成本降低之前，費用壁壘很可能會繼續阻礙市場的廣泛擴張。

技術進步

基因組技術的快速發展為市場成長帶來了巨大的機會。新一代定序、SNP基因型鑒定、人工智慧驅動的分析以及基於雲端的生物資訊等領域的創新，在提高檢測準確性的同時，也縮短了檢測週期。這些技術進步也降低了營運成本，從而擴大了檢測的覆蓋範圍。隨著檢測平台變得更有效率且便捷，企業可以將服務範圍從品種鑑定擴展到疾病預測、營養規劃和個人化護理等領域，從而在獸醫和消費市場開闢新的收入來源。

監理和倫理問題

監管和倫理方面的挑戰對市場構成潛在威脅。基因資料保護法、獸醫法規和檢測標準的區域差異使商業化進程變得複雜。關於資料所有權、育種中的基因歧視以及寵物DNA資訊濫用的倫理問題正導致審查力度加大。企業必須在不斷變化的合規框架下保持透明度和信任度。未能應對這些挑戰可能會延誤核准，並影響企業的長期市場信譽。

新冠疫情的影響

新冠疫情對伴侶動物基因體學和DNA檢測市場產生了複雜的影響。雖然供應鏈中斷和檢測實驗室的臨時關閉最初導致營運放緩，但封鎖措施促使全球寵物領養數量激增。與寵物相處時間的增加使飼主更加關注健康，從而加速了對基因檢測的興趣。疫情後的復甦期，隨著數位化訂購、居家檢體包以及與遠端獸醫服務的整合，市場需求進一步增強，並支撐了市場的韌性和長期成長。

預計在預測期內，犬種鑑定測試領域將佔據最大的市場佔有率。

由於消費者需求強勁且認知度高，品種鑑定檢測預計將在預測期內佔據最大的市場佔有率。寵物飼主越來越希望了解品種組成，以便更好地理解寵物的動態特性、體型預測和潛在健康風險。該細分市場受益於面向消費者的直銷試劑盒、簡化的結果報告以及主要企業的強力行銷。價格實惠即時實際價值，使得品種鑑定成為伴侶動物基因體學領域最廣泛採用的切入點。

預計在預測期內，SNP基因分型領域將實現最高的複合年成長率。

由於其卓越的準確性和不斷擴展的臨床應用，SNP基因分型領域預計將在預測期內實現最高成長率。基於SNP的檢測能夠精確檢測與遺傳疾病、性狀和藥物反應相關的基因變異。獸醫診所和育種者擴大採用SNP進行高級診斷和預防保健，這推動了該領域的快速成長。隨著成本的降低和數據解讀能力的提高，SNP基因分型正成為精準獸醫學的基礎技術。

比最大的地區

由於寵物擁有率上升、都市化加快以及中產階級人口不斷壯大，亞太地區預計將在預測期內佔據最大的市場佔有率。寵物健康意識提升、獸醫基礎設施的不斷完善以及數位化寵物服務的蓬勃發展，都鞏固了該地區的市場主導地位。中國、日本和澳洲等國家正迅速普及基因檢測解決方案。伴侶動物消費的強勁成長以及先進診斷技術的普及，進一步鞏固了該地區的主導地位。

複合年均成長率最高的地區

由於北美地區擁有先進的獸醫基礎設施、高額的寵物醫療保健支出以及對基因組技術的早期應用，預計該地區在預測期內將實現最高的複合年成長率。主要市場參與企業的強大影響力、面向消費者的檢測套組的廣泛普及以及寵物飼主較高的認知度，都在推動著這一成長。此外，持續的研究、創新以及將基因組學融入日常獸醫實踐的推動，也使北美成為成長最快的區域市場。

免費客製化服務

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 最多三家新增市場參與企業進行全面分析
    • 主要參與企業（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 從產品系列、地域覆蓋範圍和策略聯盟等方面對主要參與企業進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球伴侶動物基因體學和DNA檢測市場（按檢測類型分類）

  • 品種鑑定測試
  • 基因健康風險檢測
  • 疾病篩檢和帶原者檢測
  • 性狀和祖源檢測
  • 健康管理和營養基因組檢測

6. 全球伴侶動物基因體學和DNA檢測市場（按動物類型分類）

  • 狗
  • 貓
  • 馬
  • 其他動物類型

7. 全球伴侶動物基因體學和DNA檢測市場（按分銷管道分類）

  • 直接面對消費者（DTC）
  • 獸醫通知的檢查
  • 線上平台
  • 診斷實驗室

8. 全球伴侶動物基因體學和DNA檢測市場（依技術分類）

  • 基於PCR的檢測
  • 下一代定序（NGS）
  • SNP基因型分析
  • 微陣列技術
  • 全基因組定序

9. 全球伴侶動物基因體學和DNA檢測市場（按應用分類）

  • 疾病預測與預防
  • 個人化治療方案
  • 育種管理
  • 行為和特徵分析

第10章 全球伴侶動物基因體學和DNA檢測市場（依最終用戶分類）

  • 獸醫醫院和診所
  • 寵物飼主
  • 研究所
  • 育種者和品種登記組織

11. 全球伴侶動物基因體學和DNA檢測市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Neogen Corporation
  • UC Davis Veterinary Genetics Laboratory
  • Zoetis Inc.
  • ZOOGEN
  • IDEXX Laboratories
  • Generatio GmbH
  • Thermo Fisher Scientific
  • VetGen LLC
  • Mars Petcare
  • Eurofins Scientific
  • Embark Veterinary
  • Antech Diagnostics
  • Basepaws
  • Animal Genetics Inc.
  • Orivet Genetic Pet Care
Product Code: SMRC32968

According to Stratistics MRC, the Global Companion Animal Genomics & DNA Testing Market is accounted for $864.55 million in 2025 and is expected to reach $1,510.75 million by 2032 growing at a CAGR of 8.3% during the forecast period. Companion Animal Genomics & DNA Testing refers to the scientific analysis of genetic material in pets such as dogs and cats to understand their breed composition, inherited traits, health risks, and ancestry. Built on decades of classical genetics and modern molecular biology, it applies advanced DNA sequencing and bioinformatics to support preventive healthcare, personalized nutrition, responsible breeding, and disease management. This field enables veterinarians, breeders, and pet owners to anticipate hereditary conditions, optimize wellness plans, and improve quality of life. As technology advances, it is shaping the future of precision veterinary care while preserving the time-honored bond between humans and their companion animals.

Market Dynamics:

Driver:

Rising Pet Ownership & Humanization of Pets

Rising pet ownership, coupled with the deepening emotional bond between humans and their companion animals, is a major growth driver for the market. Pets are increasingly viewed as family members, prompting owners to invest in advanced healthcare, wellness monitoring, and preventive diagnostics. Genetic testing helps owners understand breed traits, behavioral tendencies, and inherited health risks early, enabling proactive care. This long-standing love for animals, now reinforced by modern science, continues to fuel sustained demand for genomics-based pet solutions.

Restraint:

High Cost of Genetic Testing

The high cost associated with companion animal genetic testing acts as a notable market restraint, particularly in price-sensitive regions. Advanced DNA sequencing, bioinformatics analysis, and laboratory infrastructure significantly increase testing expenses. For many pet owners, especially in emerging economies, these costs limit adoption despite growing awareness. Additionally, premium pricing restricts routine or repeat testing, slowing market penetration. Until testing becomes more affordable, cost barriers will continue to challenge widespread market expansion.

Opportunity:

Advances in Technologies

Rapid advancements in genomic technologies present a strong opportunity for market growth. Innovations in next-generation sequencing, SNP genotyping, AI-driven analytics, and cloud-based bioinformatics are improving accuracy while reducing turnaround time. These technological improvements are also lowering operational costs, enabling broader accessibility. As testing platforms become more efficient and user-friendly, companies can expand offerings beyond breed identification to disease prediction, nutrition planning, and personalized care, opening new revenue streams across veterinary and consumer markets.

Threat:

Regulatory & Ethical Challenges

Regulatory and ethical challenges pose a potential threat to the market. Variations in genetic data protection laws, veterinary regulations, and testing standards across regions complicate commercialization. Ethical concerns surrounding data ownership, genetic discrimination in breeding, and misuse of pet DNA information further intensify scrutiny. Companies must navigate evolving compliance frameworks while maintaining transparency and trust. Failure to address these issues could slow approvals, and impact long-term market credibility.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the companion animal genomics and DNA testing market. While supply chain disruptions and temporary laboratory closures slowed operations initially, lockdowns triggered a surge in pet adoption globally. Increased time spent with pets heightened owner awareness of pet health and wellness, accelerating interest in genetic testing. Post-pandemic recovery has strengthened demand, with digital ordering, at-home sample kits, and tele-veterinary integration supporting market resilience and long-term growth.

The breed identification testing segment is expected to be the largest during the forecast period

The breed identification testing segment is expected to account for the largest market share during the forecast period, due to strong consumer demand and widespread awareness. Pet owners increasingly seek insights into breed composition to better understand behavior, size expectations, and potential health risks. This segment benefits from direct-to-consumer test kits, simplified reporting, and strong marketing by leading players. Its affordability and immediate, tangible value make breed identification the most widely adopted entry point into companion animal genomics.

The SNP genotyping segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the SNP genotyping segment is predicted to witness the highest growth rate, due to its superior accuracy and expanding clinical applications. SNP-based testing enables precise detection of genetic variations linked to inherited diseases, traits, and drug responses. Growing adoption by veterinary clinics and breeders for advanced diagnostics and preventive care supports rapid growth. As costs decline and data interpretation improves, SNP genotyping is emerging as the backbone technology for precision veterinary medicine.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, urbanization, and expanding middle-class populations. Increasing awareness of pet healthcare, coupled with growing veterinary infrastructure and digital pet services, supports market dominance. Countries such as China, Japan, and Australia are witnessing rapid adoption of genetic testing solutions. Strong growth in companion animal spending and improving access to advanced diagnostics underpin the region's leadership.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, high pet healthcare expenditure, and early adoption of genomic technologies. Strong presence of key market players, widespread availability of direct-to-consumer testing kits, and high awareness among pet owners accelerate growth. Additionally, ongoing research, innovation, and integration of genomics into routine veterinary practice position North America as the fastest-growing regional market.

Key players in the market

Some of the key players in Companion Animal Genomics & DNA Testing Market include Neogen Corporation, UC Davis Veterinary Genetics Laboratory, Zoetis Inc., ZOOGEN, IDEXX Laboratories, Generatio GmbH, Thermo Fisher Scientific, VetGen LLC, Mars Petcare, Eurofins Scientific, Embark Veterinary, Antech Diagnostics, Basepaws, Animal Genetics Inc. and Orivet Genetic Pet Care.

Key Developments:

In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.

In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.

Test Types Covered:

  • Breed Identification Testing
  • Genetic Health Risk Testing
  • Disease Screening & Carrier Testing
  • Trait & Ancestry Testing
  • Wellness & Nutrition Genomics

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Other Animal Types

Distribution Channels Covered:

  • Direct-to-Consumer (DTC)
  • Veterinary Referral Testing
  • Online Platforms
  • Diagnostic Laboratories

Technologies Covered:

  • PCR-based Testing
  • Next-Generation Sequencing (NGS)
  • SNP Genotyping
  • Microarray Technology
  • Whole Genome Sequencing

Applications Covered:

  • Disease Prediction & Prevention
  • Personalized Treatment Planning
  • Breeding Management
  • Behavioral & Trait Analysis

End Users Covered:

  • Veterinary Clinics & Hospitals
  • Pet Owners
  • Research Institutions
  • Breeders & Kennel Clubs

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Genomics & DNA Testing Market, By Test Type

  • 5.1 Introduction
  • 5.2 Breed Identification Testing
  • 5.3 Genetic Health Risk Testing
  • 5.4 Disease Screening & Carrier Testing
  • 5.5 Trait & Ancestry Testing
  • 5.6 Wellness & Nutrition Genomics

6 Global Companion Animal Genomics & DNA Testing Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Horses
  • 6.5 Other Animal Types

7 Global Companion Animal Genomics & DNA Testing Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (DTC)
  • 7.3 Veterinary Referral Testing
  • 7.4 Online Platforms
  • 7.5 Diagnostic Laboratories

8 Global Companion Animal Genomics & DNA Testing Market, By Technology

  • 8.1 Introduction
  • 8.2 PCR-based Testing
  • 8.3 Next-Generation Sequencing (NGS)
  • 8.4 SNP Genotyping
  • 8.5 Microarray Technology
  • 8.6 Whole Genome Sequencing

9 Global Companion Animal Genomics & DNA Testing Market, By Application

  • 9.1 Introduction
  • 9.2 Disease Prediction & Prevention
  • 9.3 Personalized Treatment Planning
  • 9.4 Breeding Management
  • 9.5 Behavioral & Trait Analysis

10 Global Companion Animal Genomics & DNA Testing Market, By End User

  • 10.1 Introduction
  • 10.2 Veterinary Clinics & Hospitals
  • 10.3 Pet Owners
  • 10.4 Research Institutions
  • 10.5 Breeders & Kennel Clubs

11 Global Companion Animal Genomics & DNA Testing Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Neogen Corporation
  • 13.2 UC Davis Veterinary Genetics Laboratory
  • 13.3 Zoetis Inc.
  • 13.4 ZOOGEN
  • 13.5 IDEXX Laboratories
  • 13.6 Generatio GmbH
  • 13.7 Thermo Fisher Scientific
  • 13.8 VetGen LLC
  • 13.9 Mars Petcare
  • 13.10 Eurofins Scientific
  • 13.11 Embark Veterinary
  • 13.12 Antech Diagnostics
  • 13.13 Basepaws
  • 13.14 Animal Genetics Inc.
  • 13.15 Orivet Genetic Pet Care

List of Tables

  • Table 1 Global Companion Animal Genomics & DNA Testing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Companion Animal Genomics & DNA Testing Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 3 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breed Identification Testing (2024-2032) ($MN)
  • Table 4 Global Companion Animal Genomics & DNA Testing Market Outlook, By Genetic Health Risk Testing (2024-2032) ($MN)
  • Table 5 Global Companion Animal Genomics & DNA Testing Market Outlook, By Disease Screening & Carrier Testing (2024-2032) ($MN)
  • Table 6 Global Companion Animal Genomics & DNA Testing Market Outlook, By Trait & Ancestry Testing (2024-2032) ($MN)
  • Table 7 Global Companion Animal Genomics & DNA Testing Market Outlook, By Wellness & Nutrition Genomics (2024-2032) ($MN)
  • Table 8 Global Companion Animal Genomics & DNA Testing Market Outlook, By Animal Type (2024-2032) ($MN)
  • Table 9 Global Companion Animal Genomics & DNA Testing Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 10 Global Companion Animal Genomics & DNA Testing Market Outlook, By Cats (2024-2032) ($MN)
  • Table 11 Global Companion Animal Genomics & DNA Testing Market Outlook, By Horses (2024-2032) ($MN)
  • Table 12 Global Companion Animal Genomics & DNA Testing Market Outlook, By Other Animal Types (2024-2032) ($MN)
  • Table 13 Global Companion Animal Genomics & DNA Testing Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 14 Global Companion Animal Genomics & DNA Testing Market Outlook, By Direct-to-Consumer (DTC) (2024-2032) ($MN)
  • Table 15 Global Companion Animal Genomics & DNA Testing Market Outlook, By Veterinary Referral Testing (2024-2032) ($MN)
  • Table 16 Global Companion Animal Genomics & DNA Testing Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 17 Global Companion Animal Genomics & DNA Testing Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 18 Global Companion Animal Genomics & DNA Testing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Companion Animal Genomics & DNA Testing Market Outlook, By PCR-based Testing (2024-2032) ($MN)
  • Table 20 Global Companion Animal Genomics & DNA Testing Market Outlook, By Next-Generation Sequencing (NGS) (2024-2032) ($MN)
  • Table 21 Global Companion Animal Genomics & DNA Testing Market Outlook, By SNP Genotyping (2024-2032) ($MN)
  • Table 22 Global Companion Animal Genomics & DNA Testing Market Outlook, By Microarray Technology (2024-2032) ($MN)
  • Table 23 Global Companion Animal Genomics & DNA Testing Market Outlook, By Whole Genome Sequencing (2024-2032) ($MN)
  • Table 24 Global Companion Animal Genomics & DNA Testing Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global Companion Animal Genomics & DNA Testing Market Outlook, By Disease Prediction & Prevention (2024-2032) ($MN)
  • Table 26 Global Companion Animal Genomics & DNA Testing Market Outlook, By Personalized Treatment Planning (2024-2032) ($MN)
  • Table 27 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breeding Management (2024-2032) ($MN)
  • Table 28 Global Companion Animal Genomics & DNA Testing Market Outlook, By Behavioral & Trait Analysis (2024-2032) ($MN)
  • Table 29 Global Companion Animal Genomics & DNA Testing Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Companion Animal Genomics & DNA Testing Market Outlook, By Veterinary Clinics & Hospitals (2024-2032) ($MN)
  • Table 31 Global Companion Animal Genomics & DNA Testing Market Outlook, By Pet Owners (2024-2032) ($MN)
  • Table 32 Global Companion Animal Genomics & DNA Testing Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 33 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breeders & Kennel Clubs (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.